242 related articles for article (PubMed ID: 25708803)
1. Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach?
Chen X; Eads JR; Ammori JB; Kumar AM; Biswas T; Dorth JA
Curr Oncol Rep; 2015 Apr; 17(4):18. PubMed ID: 25708803
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.
Knight G; Earle CC; Cosby R; Coburn N; Youssef Y; Malthaner R; Wong RK;
Gastric Cancer; 2013 Jan; 16(1):28-40. PubMed ID: 22467061
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant and neoadjuvant approaches in gastric cancer.
Ng K; Meyerhardt JA; Fuchs CS
Cancer J; 2007; 13(3):168-74. PubMed ID: 17620766
[TBL] [Abstract][Full Text] [Related]
4. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
Slagter AE; Jansen EPM; van Laarhoven HWM; van Sandick JW; van Grieken NCT; Sikorska K; Cats A; Muller-Timmermans P; Hulshof MCCM; Boot H; Los M; Beerepoot LV; Peters FPJ; Hospers GAP; van Etten B; Hartgrink HH; van Berge Henegouwen MI; Nieuwenhuijzen GAP; van Hillegersberg R; van der Peet DL; Grabsch HI; Verheij M
BMC Cancer; 2018 Sep; 18(1):877. PubMed ID: 30200910
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Management of Gastric and Gastroesophageal Cancers.
Kamran SC; Hong TS; Wo JY
Curr Oncol Rep; 2016 Feb; 18(2):13. PubMed ID: 26769118
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant treatment for locally advanced gastric cancer: an Asian perspective.
Kim HD; Ryu MH; Kang YK
Gastric Cancer; 2024 May; 27(3):439-450. PubMed ID: 38489111
[TBL] [Abstract][Full Text] [Related]
8. Multimodality treatment for localized gastric cancer: state of the art and new insights.
Petrillo A; Smyth EC
Curr Opin Oncol; 2020 Jul; 32(4):347-355. PubMed ID: 32541324
[TBL] [Abstract][Full Text] [Related]
9. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
10. KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer.
Bang YJ; Van Cutsem E; Fuchs CS; Ohtsu A; Tabernero J; Ilson DH; Hyung WJ; Strong VE; Goetze TO; Yoshikawa T; Tang LH; Hwang PMT; Webb N; Adelberg D; Shitara K
Future Oncol; 2019 Mar; 15(9):943-952. PubMed ID: 30777447
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
Kretzschmar A; Schlag PM
Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant and neoadjuvant therapy for gastric cancer.
Oh DY; Bang YJ
Curr Treat Options Oncol; 2013 Sep; 14(3):311-20. PubMed ID: 23686725
[TBL] [Abstract][Full Text] [Related]
13. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
Choi AH; Kim J; Chao J
World J Gastroenterol; 2015 Jun; 21(24):7343-8. PubMed ID: 26139980
[TBL] [Abstract][Full Text] [Related]
14. Great Debate: Chemoradiation Should be Added to Chemotherapy as a Neoadjuvant Treatment Strategy for Resectable Gastric Adenocarcinoma.
Daniel SK; Badgwell BD; McKinley SK; Strong VE; Poultsides GA
Ann Surg Oncol; 2024 Jan; 31(1):405-412. PubMed ID: 37865940
[TBL] [Abstract][Full Text] [Related]
15. TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG.
Leong T; Smithers BM; Haustermans K; Michael M; Gebski V; Miller D; Zalcberg J; Boussioutas A; Findlay M; O'Connell RL; Verghis J; Willis D; Kron T; Crain M; Murray WK; Lordick F; Swallow C; Darling G; Simes J; Wong R
Ann Surg Oncol; 2017 Aug; 24(8):2252-2258. PubMed ID: 28337660
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Therapies in the Perioperative Management of Gastric Cancer.
Khan U; Shah MA
Curr Treat Options Oncol; 2019 May; 20(7):57. PubMed ID: 31144054
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in multimodal treatment for gastric cancer: a review.
Lordick F; Siewert JR
Gastric Cancer; 2005; 8(2):78-85. PubMed ID: 15864714
[TBL] [Abstract][Full Text] [Related]
18. Management of gastric cancer.
Ku GY; Ilson DH
Curr Opin Gastroenterol; 2014 Nov; 30(6):596-602. PubMed ID: 25197781
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant and neoadjuvant therapy of gastric cancer: a comparison of three pivotal studies.
Sano T
Curr Oncol Rep; 2008 May; 10(3):191-8. PubMed ID: 18765148
[TBL] [Abstract][Full Text] [Related]
20. [Perioperative chemotherapy vs. surgery alone in resectable gastroesophageal carcinomas. Results of the MAGIC study].
Lordick F; Siewert JR
Chirurg; 2006 Dec; 77(12):1166-7. PubMed ID: 17091285
[No Abstract] [Full Text] [Related]
[Next] [New Search]